Clostridium difficile is recognized as the major cause of antibiotic-associated colitis. C. difficile produces two toxins, A (enterotoxin) and B (cytotoxin) The major recognized cause of antibiotic-associated colitis is cytotoxigenic Clostridium difficile (3, 6) . C. difficile produces two toxins (A and B) which are implicated in the pathogenesis of the colitis (1, 6, 29, 31). C. difficile toxin A has both enterotoxic and cytopathic activities, and toxin B is a potent cytotoxin (1, 20) . Toxin A causes fluid accumulation associated with mucosal damage in several animal models: rabbit ileal and colonic loops (1, 27; A. A. M. Lima et al., Abstr. Clin. Res. 34:442A, 1986), hamster cecal segments (24), and mouse and rat intestine (24). Toxin B has no enterotoxic activity (1, 20, 24) but is a more potent cytotoxin than toxin A in tissue culture lines by approximately 1,000-fold (1, 20). Both toxins cause erythematous and hemorrhagic lesions in rabbit and guinea pig skin (1, 20), and both toxins are lethal to mice, with toxin A having about the same potency as toxin B when injected intraperitoneally (23). In addition, toxin A is lethal to rabbits when high doses are placed in ligated ileal loops (24). The mechanism by which toxin A causes intestinal secretion and cell damage is unknown, and the relevance of the cytopathic activities of toxins A and B to fluid secretion in the intestine is unclear.
rabbit large intestine, and in contrast to its effect in small intestine, crude toxin caused net accumulation of bicarbonate and increased pH. In tissue culture, toxin A caused a rounding up of CHO and T-84 colonic carcinoma cells. A monoclonal antibody (PCG-4) that has no effect on tissue culture cytotoxicity with toxins A and B completely inhibited the secretory and tissue-damaging effects in the intestine. Toxins A and B were synergistic in the gut only at high doses of toxin B (. 10 ,ug/ml), and they were additive in tissue culture. The cytopathic effect in tissue culture was not consistently associated with trypan blue uptake. The cytopathic effect of toxin A in tissue culture did not appear to involve inhibitable Ca2+-dependent or prostaglandin synthesis pathways or intact microfilament or microtubule function for its activity and was not inhibited by reducing or lysosomotropic agents. Our results suggest that toxins A and B have independent and distinct effects in vivo and in vitro.
The major recognized cause of antibiotic-associated colitis is cytotoxigenic Clostridium difficile (3, 6) . C. difficile produces two toxins (A and B) which are implicated in the pathogenesis of the colitis (1, 6, 29, 31) . C. difficile toxin A has both enterotoxic and cytopathic activities, and toxin B is a potent cytotoxin (1, 20) . Toxin A causes fluid accumulation associated with mucosal damage in several animal models: rabbit ileal and colonic loops (1, 27 ; A. A. M. Lima et al., Abstr. Clin. Res. 34:442A, 1986), hamster cecal segments (24) , and mouse and rat intestine (24) . Toxin B has no enterotoxic activity (1, 20, 24) but is a more potent cytotoxin than toxin A in tissue culture lines by approximately 1,000-fold (1, 20) . Both toxins cause erythematous and hemorrhagic lesions in rabbit and guinea pig skin (1, 20) , and both toxins are lethal to mice, with toxin A having about the same potency as toxin B when injected intraperitoneally (23) . In addition, toxin A is lethal to rabbits when high doses are placed in ligated ileal loops (24) . The mechanism by which toxin A causes intestinal secretion and cell damage is unknown, and the relevance of the cytopathic activities of toxins A and B to fluid secretion in the intestine is unclear.
The purpose of these studies was to compare the dose responses, time courses, and synergism of purified C. difficile toxins A and B in ligated rabbit small and large intestine and in tissue culture cells. In addition, the cytopathic effect of toxin A seen in tissue culture cells in vitro was explored to examine the possible mechanisms of the cytopathic effect of this toxin, using potential pharmacologic blockers. Toxin A and toxin B were purified to homogeneity from culture filtrate of C. difficile VPI 10463 as previously described (23) . Briefly, toxin A was purified by ammonium sulfate precipitation, ion-exchange chromatography on DEAE-Sepharose CL-6B, and precipitation at pH 5.6 . Toxin B was purified by ammonium sulfate precipitation, ionexchange chromatography on DEAE-Sepharose CL-6B, and immunoaffinity chromatography. Both toxins were homogeneous as shown by crossed immunoelectrophoresis and polyacrylamide gel electrophoresis.
Cholera toxin was purchased from Schwarz/Mann (Spring Valley, N.Y.). PCG-4 monoclonal antibody raised against purified toxin A was prepared by standard methods (22) and is an immunoglobulin G2a(K) isotype. This antibody has been reported to neutralize the enterotoxic activity of toxin A (21) . For these studies, the PCG-4 monoclonal antibody in ascites fluid of BALB/c mice was used at 1:10 dilution (22) . Ascites fluid containing P8H3 monoclonal antibody was used in our studies as a negative control reagent. The P8H3 antibody was obtained against a different clostridial species and does not react with C. difficile or its antigens (C. Phelps and T. Wilkins, unpublished data).
Ligated rabbit small and large intestine assays in vivo. Male new Zealand White rabbits (1.5 to 2.5 kg) were used in all studies. Animals were fasted overnight but were given water ad libitum.
Ligated rabbit small intestinal segments (5 cm) were injected with 1 ml of crude filtrate toxin, highly purified toxin A or B from C. difficile, or control material (Ringer solution or heat-inactivated toxin). After difficile toxin A-induced secretion in ligated small intestinal loops at 6 h is shown in Fig. 1 . At 1 ,ug/ml, toxin A produced hemorrhagic secretion with a ratio of 0.35 ml/cm, while 10 ,ug/ml of toxin A produced a ratio of 1.65 ml of hemorrhagic fluid secretion per cm (P < 0.001). Heat treatment (100°C for 30 min) abolished the secretory effect. The secretory effect was also completely blocked by prior incubation of the toxin for 30 min at 37°C with a monoclonal antibody (PCG-4, 1:10 dilution) specific for the toxin. Figure 2 shows the time course of C. difficiie toxin A-induced secretion in ligated small intestinal segments. Toxin A at 10 ,ug/ml was studied at 2 to 18 h postinoculation. After 2 h, hemorrhagic secretion (0.33 ml/cm) occurred and steadily increased over 18 h (ratio of volume/length, 2.18 ± 0.17 ml/cm; range, 1.86 to 2.45 ml/cm) to a range comparable to that seen at 18 h with 1 gxg of cholera toxin per ml (ratio of volume/length, 2.27 ± 0.19 ml/cm; range, 1.41 to 2.91 ml/cm). The onset of fluid secretion with toxin A was slightly faster than with cholera toxin as it approaches maximum as early as 6 h (Fig. 2 ). When we examined for synergistic intestinal effects with toxins A and B, significant secretory effect was seen only at high doses of toxin B (.10 ,ug/ml) (Table 1) .
Crude culture filtrates at 1:10 dilution produced significant 1.07 ± 0.09 ml/cm) and tissue damage in small intestinal segments at 6 to 8 h (Table 2) . Heated (100°C, 30 min) filtrates were inactive.
Colonic loop studies. Figure 3 shows the time course of C. difficile crude filtrate toxin-induced secretion in rabbit colonic loops. Crude toxin (1:10 dilution) effects were studied at 8 to 18 h. There was significant fluid accumulation, but this was less hemorrhagic than seen in small intestinal segments at 12 h; at 18 h fluid accumulation to a range comparable to that seen in small intestinal segments studies occurred. The time course of secretion seen with C. difficile toxin in colonic loops was delayed compared with that in small intestinal loop studies (Table 2) . Neither toxin A (10 ,g/ml) nor toxin B (10 ,g/ml) alone or together caused secretion or mucosal damage over 2 to 18 h in rabbit colonic loops, suggesting that other factors are involved in the effect of C. difficile in the colon. Only at 250 p,g/ml did purified toxin A cause colonic secretion similar to that seen with crude toxins (data not shown).
Fluid secretion studies. Table 2 summarizes the intestinal fluid electrolyte content, total protein, albumin, osmolality, and pH after 6 to 8 h of fluid accumulation in small intestinal loops in vivo induced by crude culture filtrate (1:10 dilution in Ringer solution), toxin A, and cholera toxin. C. difficile crude toxin induced a significant net accumulation of sodium, chloride, and potassium (P s 0.03), but did not cause significant bicarbonate accumulation. In contrast to cholera toxin, crude C. difficile toxin showed significant net accumulation of total protein (31.4 ± 4.0 mg/cm, P = 0.01). The major protein found was albumin (24 + 3.1 mg/cm, P = 0.009) which represented 77% (24/31 mg/cm) of the total protein content in the fluid. The osmolality was greater (328 ± 2.4 mosmol/kg, P = 0.008) with C. difficile filtrate crude toxin than with heated controls. A similar but smaller effect was seen with toxin A as well as with cholera toxin. In contrast to cholera toxin, crude C. difficile toxin caused a significant decrease (P < 0.025) in the pH of the intestinal fluid compared with the alkaline pH seen with the control heat-inactivated toxin. C. difficile toxin A (10 p,g/ml), like cholera toxin (1 ,ug/ml), caused net accumulation of sodium, chloride, and potassium (P < 0.025). Neither purified toxin A nor crude C. difficile toxin caused bicarbonate secretion in the small intestine like that seen with cholera toxin (Table 2 ). However, crude C. difficile toxin did cause net bicarbonate secretion (with other electrolytes) in the large intestine that was significant by 12 h and increased further by 18 h (Table 3 ). C. difficile crude toxin, toxin A, and cholera toxin showed similar intestinal fluid accumulation and increased osmolality in small bowel. In contrast to the effect of cholera toxin, but similar to crude C. difficile toxin, purified toxin A caused a significant increase of the total protein (P < 0.025). (Fig. 4) . Pretreatment of toxin A (10 ,ug/ml) with monoclonal antibody PCG-4 (1:10 dilution of ascites) completely prevented the toxin-induced intestinal damage and its secretory effect at 6 h.
To determine the time of toxin exposure required for subsequent effects, we placed toxin A (3 ,g/ml) and Tris buffer control in adjacent loops for 5 min, after which they were removed and the segments were washed three times with Ringer solution. The loops were then returned to the abdomen for the full 5-h period before the animal was sacrificed and the loop histology was determined. Loops that had been treated with toxin A and subsequently washed showed secretory responses with disrupted vili after 5 h with pathology similar to that described above. toxin A, we examined reducing agents, calcium antagonists, prostaglandin synthesis inhibitors, microfilament and microtubule inhibitors, and lysosomotropic agents for their effects with toxin A on CHO cells (Table 4 ). The dose of toxin A used was 0.5 ,ug/ml (the minimum dose of toxin which consistently caused rounding of 100% of CHO cells). The potential pharmacologic blockers were added 30 min before toxin A. All experiments were done in duplicate wells, in at least three different studies with serial log dilutions of each drug at 10-3 to 10-6 M. The concentrations of the drugs shown in Table 4 are the maximum doses that produced no morphologic changes in CHO cells alone. Of all the pharmacologic agents tested, none blocked the cytopathic effect of toxin A when compared with Tris buffer controls or drugs alone.
To determine the minimum time required for toxin A to cause cytopathic effect on CHO cells, we incubated toxin A on CHO cells for 5 min, after which it was removed and each well was washed two times with phosphate-buffered saline. Each well was filled with F12 medium supplemented with 1% fetal calf serum and returned to the incubator at 37°C for 24 h. The cytopathic effect of toxin A on CHO cells was rinsable in that two changes with fresh medium after a 5-min exposure to toxin A resulted in a 100-fold reduction in toxin effect. However, this cytopathic effect was not altered or reversed by rinsing after 24 h of toxin exposure. A similar cytopathic effect on the T-84 human colonic carcinoma cells was observed.
We also examined for any additive or synergistic cytopathic effect on CHO cells with toxins A and B (Fig. 5) ; toxin A at 20.5 ,ug/ml or toxin B at .0.2 ng/ml caused rounding of CHO cells, an effect that was additive with subeffective doses of the other toxin.
To evaluate further the possible correlation of toxin A effects on the intestine in vivo and in tissue culture in vitro, we used the same monoclonal antibody (PCG-4) that completely blocks secretory and intestinal mucosa-damaging effects of toxin A. Toxin A or B was treated with monoclonal antibody for 30 min at 37°C before the toxin-antibody mixture was added to CHO cells in vitro. The cytopathic effect caused by toxin A or toxin B at different doses was not altered by the PCG-4 monoclonal antibody when compared with an unrelated P8H3 monoclonal antibody or phosphatebuffered saline control. DISCUSSION C. difficile is now recognized as the major cause of antibiotic-associated colitis (2, 5, 6, 11) . A substantial body of data implicate a role for toxin A and toxin B in the colitis and diarrhea seen with C. difficile infection (5, 12, 18, 19, 24, 27) . Immunization against both toxins but not against either alone protects against systemic disease in experimental animals (12, 19) . Both toxins are consistently detected in fecal specimens from humans and experimental animals; thus, both toxins are produced during the disease (25) . C. difficile toxin also correlates well with antibiotic-associated pseudomembranous colitis (4). The disease is usually associated with gross and histologic damage to the colonic mucosa as well as watery diarrhea (90 to 95%), less frequent bloody diarrhea (5 to 10%), and hypoalbuminemia (4). A cytopathic effect of both C. difficile toxins has also been shown in tissue culture (10, 31) . However, the correlation between the tissue culture cytopathic effect and enterotoxic effect of C. difficile toxin and severity of the disease as well as the role of intestinal tissue-damaging effects on the secretory process are unclear. The CHO cell tissue culture assay for toxin is the preferred method to establish the diagnosis of C. difficile-induced diarrhea or colitis (4), even though there is no good correlation between fecal C. difficile toxin titer and severity of the disease (7) . In this study, we found that C. difficile toxin A initially causes a viscous (at 2 h) and then hemorrhagic fluid secretion that steadily increases over 18 h in ligated rabbit small intestinal segments. These segments usually showed macroscopically hemorrhagic mucosa by 6 h. In contrast, cholera toxin caused clear watery fluid with no gross or microscopic mucosal damage. The amount of secretion caused by 10 ,ug of toxin A per ml was, however, comparable to that seen with 1 ,ug of cholera toxin per ml after 18 h. On the basis of their relative molecular weights (toxin A, -450,000; cholera toxin, ==82,000), the molar amount of toxin A (10 ,ug/ml or 2.2 x 10-8 mol) required for a striking effect in rabbit small intestinal segments was similar to that of cholera toxin (1 ,ug/ml or 1.22 x 10-8 mol).
Toxin A caused intestinal tissue damage as early as 2 h; thus, we saw no fluid secretion without mucosal cell damage. From these results, toxin A causes secretion only at doses and times when histologic intestinal tissue damage was also seen. This is in contrast to a report by Hughes et al. Toxin A (10 ,ug/ml) caused significant secretion of electrolytes (Table 2 ) by 6 h in rabbit small intestine, a response similar to that seen with cholera toxin (except for bicarbonate). However, unlike cholera toxin, toxin A caused an increase in total protein in the intestine, which further fits the close association of fluid accumulation with the tissuedamaging effect of the crude or purified toxin.
Toxin A at doses of 23 ,ug/ml plus toxin B at .10 ,ug/ml caused a synergistic secretory effect in rabbit small intestine by 6 h (five different animals) ( Table 1 ). In the large intestine, neither toxin A (at 10 ,ug/ml) nor toxin B (at 10 jig/ml) showed any secretory effect separately or together at 8, 12, or 18 h (two to four loops for each point, in two different animals). Synergistic effects were seen only in the rabbit small intestine with toxin B concentrations .10 ,ugIml, very high concentrations that are often not present in stool specimens of patients with C. difficile colitis. The usual cytotoxin titer of 1:100 to 1:1,000 in patient stool specimens would be equivalent to 0.06 to 0.6 ,ug/ml, respectively (based on a cytotoxin titer50 in CHO cells, an amount that rounds -50% of the cells, of 0.0006 ,ug of toxin B per ml). However, on August 27, 2017 by guest http://iai.asm.org/ Downloaded from this could be relevant in patients with very high cytotoxin titers of .1:10,000 in fecal specimens. At the usual cytotoxin titers seen in patients, we would expect no synergistic activity. A previous report by Lyerly et al. (24) showed that toxins A and B are synergistic only with respect to the systemic effects of lethargy and death when given intragastrically to hamsters. Necropsy of these animals showed only small amounts of mucus and edema in the intestine. In contrast to a report by Mitchell et al. (27) , we found secretory and tissue-damaging effects with toxin A only at high doses (.50 ,ugIml) in the rabbit large intestine. However, we did find a time course of the secretory response using crude filtrate C. difficile toxin that was similar to theirs (27) . Additionally, our negative results with toxin B in the large intestine agree with those of Mitchell et al. (27) . The dosage differences with our findings might be explained by different C. difficile toxin preparations or possibly by the presence of a factor(s) in the rabbit large intestine, different from the small intestine, that might influence the effects of C. difficile toxin.
As with purified toxin A, our determination of the fluid secretion composition in both small and large rabbit intestine with crude filtrate toxin showed significant leakage of protein (specifically albumin) into the intestinal lumen, in association with mucosal tissue damage. This protein loss might explain in part the hypoalbuminemia seen with C. difficile disease (4). The physiologic pH in the rabbit small intestine also fits with extravasion or equilibration with the plasma fluid (in contrast to the alkaline pH seen in the control group). This result was not associated with changes in bicarbonate accumulation. However, rabbit large intestine showed an increase in the pH that was associated with an increased bicarbonate in the luminal fluid at 12 or 18 h. These results suggest that, in addition, net bicarbonate secretion is seen in the rabbit large intestine exposed to crude C. difficile toxin.
Lyerly et al. (22) have developed several monoclonal antibodies which react with homogeneous preparations of toxin A. One of these antibodies, designated PCG-4, precipitates toxin A. This antibody neutralizes the enterotoxic but not the cytotoxic activity of toxin A. We used the PCG-4 monoclonal antibody to show that it not only completely inhibits fluid accumulation in rabbit small intestinal segments, but also completely blocks the intestinal tissue damage caused by toxin A. Because PCG-4 did not inhibit the cytopathic effect of toxin A in CHO or T-84 human colonic carcinoma cells in vitro, these data suggest that the secretory response in intestinal loops in vivo seen with toxin A occurs by a different mechanism from that of the cytopathic effect in CHO and T-84 cells in vitro. These findings clearly separate the cytopathic effect of toxin A on cell cultures in vitro from the intestinal secretion seen with toxin A in vivo.
The cytopathic effects seen with toxin A and B did not appear to involve cell membrane damage as grossly examined by trypan blue exclusion in in vitro studies. The mechanism involved in the cytopathic effect of toxin A in tissue culture in vitro did not appear to involve inhibitable Ca2"-dependent (8, 17, 28) or prostaglandin synthesis (14) pathways or intact microfilament or microtubule function for its activity and was not inhibited by reducing (13, 26) or lysosomotropic (16) agents. In addition, toxin A and toxin B appear to have additive cytopathic effects in tissue culture.
In summary, toxin A causes intestinal mucosal damage that precedes intestinal fluid accumulation, and these effects were time and dose dependent. Toxin B alone did not cause intestinal tissue damage or fluid accumulation and had a synergistic effect only when used at high doses (.10 xg/ml) with toxin A (.3 ,ug/ml) in the small intestine. Toxins A and
